| Document Date: 2014-03-27 02:03:42
Open Document File Size: 1,07 MBShare Result on Facebook
City Seoul / / Company Hanmi Pharmaceutical / 3Hanmi Pharmaceutical Co. Ltd. / / Country Korea / / Event Person Communication and Meetings / / Facility Seoul National University Hospital / Seoul National University Bundang Hospital / / IndustryTerm real time / / MedicalCondition several cancer / Tumor / inflammation Rhinorrhoea Acne Infections / pulmonary dysfunction / advanced solid tumor Tumor / Active/symptomatic CNS metastases / NSCLC / advanced non-small cell lung cancer / diarrhea / infestations Paronychia Nausea Anal erosion Vomiting Dermatitis / advanced solid tumors / solid tumors / several lung cancer / L et al. Endocr Relat Cancer / advanced solid tumor / syndrome / J Cancer / tumor volume Tumor / / MedicalTreatment chemotherapy / radiotherapy / hormone therapy / surgery / chemotherapies / / MusicGroup Nausea / / Organization Seoul National University Bundang Hospital / Seoul National University Hospital / / Person Safety / Kyung Joon / Jong Seok / Tae Min / / Position investigator / / Technology chemotherapy / /
SocialTag |
Abstract # 2029 Phase I study of HM781-36B, an irreversible pan-HER tyrosine kinase inhibitor (TKI) in patients with advanced solid tumor and the therapeutic potential in patients with advanced non-small cell lung cance